Abstract:OBJECTIVE:To understand the HBV infection rate of peripheral blood mononuclear cells (PBMCs) from fetuses of HBsAg positive mothers, associated risk factors and to explore the clinical significance of detecting HBV infected PBMCs.METHODS:Sixty eight pregnant women who were delivered at the First Hospital of Xi'an Jiaotong University, China from August 1995 to February 1997, and their newborns were studied. They were divided into two groups according to their status of HBV serological markers. The study group included 50 cases who were serum HBsAg positive and 18 cases without any HBV serum markers served as control group. All these cases had no symptoms of hepatitis, high risk premature labor, premature delivery and hypertensive disorder complicating pregnancy. Age and gestational age were matched in two groups. Blood samples (5 mL) were taken from the peripheral vein of pregnant women before delivery and from newborns within 24 h after birth, before inoculation of HBV vaccine (HBVac) and injection of hepatitis B immunoglobulin (HBIG). PBMCs were isolated. The sera and PBMCs were stored at -80 degrees C. HBV-DNA in serum and PBMCs were detected with nested polymerase chain reaction (n-PCR). Two pairs of oligonucleotide primers, the outer primer pair for first PCR and inner primer pair for second PCR, designed according to region S of HBV genome were synthesized by Shanghai Cell Biology Institute of Chinese Academy of Science.RESULTS:The detection rate of HBV-DNA in serum and PBMCs from HBsAg positive pregnant women was 60.0% (30/50) and 40.0% (20/50), respectively. The detection rate of HBV-DNA in serum and PBMCs from newborns of HBsAg positive pregnant women was 46.0% (23/50) and 30.0% (15/50), respectively. Ten newborns were HBV-DNA positive in serum only, 2 were positive in PBMCs only and 13 were positive in both serum and PBMCs. In the control group, HBV-DNA was not detected in PBMC nor in serum. The positive rate of HBV-DNA in PBMCs of newborns was significantly higher in the group of mothers who were HBV-DNA or HBeAg positive in serum (P < 0.05, P < 0.01); the positive rate was significantly higher in the group of mothers who were HBV-DNA positive in both serum and PBMC than that in the group of mothers who were serum HBV-DNA positive only (P < 0.01); and it was markedly higher in the group of mothers who were PBMC HBV-DNA positive than that in group of mothers who were HBV-DNA negative in PBMCs (P < 0.01). The positive rate of HBV-DNA in PBMCs of newborns was significantly higher in the group of newborns who were HBV-DNA positive in serum than that in the group of newborns who were HBV-DNA negative in serum (P < 0.05).CONCLUSIONS:The positive rate of HBV-DNA in PBMCs from newborns of HBsAg positive pregnant women was 30.0% (15/30). It was related to HBV viremia level and HBV-DNA status in PBMCs of mothers and newborns. Detection of HBV-DNA in PBMCs may be an important supplementary method to determine intrauterine HBV infection, and can predict the response to HBV vaccine.

The Pre Liminary Study on the Expression of HBVDNA in the Thymus Tissue of the Died Fetus That Delivery by Pregnant Women Infected with Hepatitis Virus B

The Expression of HBVDNA in the Kidney Tissues of the Died Fetus That the Puerperal Delivery with Hepatitis Virus B

The clinical and pathological study on the expression of HBVDNA in the cerebral tissues of the died fetus that the puerperal delivery with hepatitis virus B

Expression of HBV-DNA in the Umbilical Cord Tissues of the Dead Fetus Delivered from Puerperant with Hepatitis Virus B Infection

Expression of HBVDNA in placenta tissues of dead fetus

Observation on the Expression of HBV-DNA in the Umbilical Cord Tissuesof the Died Fetus Delivered from Puerpera with Hepatitis Virus B

Preliminary Study on the Expression of HBV-DNA in the Cardiac Tissues of Dead Fetuses

Study on quantitative detection of HBV DNA in serum or breast milk of parturients

The presence and expression of the hepatitis B virus in human oocytes and embryos

Effect of Prophylactic Antiviral Intervention on T Cell Immunity in Hepatitis B Virus-Infected Pregnant Women

Impaired CD8+ T Cells in Term Pregnancy Decidua with Chronic Hepatitis B Virus Infection

Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates

Relationship Between HBV Viremia Level of Pregnant Women and Intrauterine Infection:Neated PCR for Detection of HBV DNA.

The Study on the Role of Hepatitis B Virus X Protein and Apoptosis in HBV Intrauterine Infection

A molecular epidemiological study on the intrauterine transmission of hepatitis B

The study on role of peripheral blood mononuclear cell in HBV intrauterine infection

Role of Hepatitis B Virus X Protein in Intrauterine Infection

Study interrelated of Hepatitis B Virus Transmission from Mothers to Infants with HBV-DNA quantitive PCR

[Clinical Significance of Detecting Neonatal Peripheral Blood Mononuclear Cells Infected by HBV].

Analysis of the HBV Infection Status in HBsAg Positive Pregnant Women Prior to Their Delivery

Study on the Maternal and Fetal Cellular Immune Status in HBsAg-positive Pregnant Women